Biotechnology News

November 8, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision reports third quarter 2012 financial results and updates on the advancement of its clinical-stage programs.

November 8, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Human Metabolome Technologies, Inc., (HMT) expands to U.S., opening office in Cambridge, Mass

November 8, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2012 Financial and Operating Results

November 8, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB: ACTC) (“ACT” or the “Company”), a leader in the field of regenerative medicine, announced today third quarter financial results for the period ended September 30, 2012....

November 8, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces Third Quarter 2012 Financial Results: –Business Update / Quarterly Conference Call November 8, 2012, at 5:00 PM EST –

November 8, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (NASDAQ: AFFY) today reported financial results for the third quarter ended September 30, 2012. The net loss for the third quarter of 2012 was $24.6 million (or ($0.68) per share) compared to a...

November 8, 2012

SEATTLE--(BUSINESS WIRE)--Davis Wright Tremaine LLP today announced that its client, Richard J. Klein, former chief financial officer of the Seattle biopharmaceutical company Omeros Corporation, has received a $3.94 million payment to settle his...

November 8, 2012

WEST ORANGE, N.J.--(BUSINESS WIRE)--After four straight quarters of moderate growth in hiring demand, the ZRG Global Life Sciences Hiring index posted a 12.1% decrease, ending the quarter at 77.2%.

November 8, 2012

PHOENIX--(BUSINESS WIRE)--Greater Phoenix launches unique program after California passes $6 billion tax initiative

November 8, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX, Phenomenex and Peak Scientific take mobile laboratory on European MASStastic Voyage Tour

November 8, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corp., a leader in the development of innovative drug candidates to address significant diseases of the eye, today announced that a multi-center, randomized, double-masked, placebo-...

November 8, 2012

DENVER--(BUSINESS WIRE)--April Giles, Executive Vice President of the Colorado BioScience Association (CBSA), has been named President & CEO following a national executive search.

November 8, 2012

SAN DIEGO--(BUSINESS WIRE)--New Studies Presented at the 2012 U.S. Psychiatric and Mental Health Congress Explore the Role of L-Methylfolate in Antidepressant Therapy

November 8, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) (Alexion or the Company) today announced that the Company’s Board of Directors has authorized the repurchase of up to $400 million of Alexion common stock. Under the...

November 8, 2012

ANAHEIM, Calif.--(BUSINESS WIRE)--During the ACAAI annual meeting, Physicians are Reminded of the Need to Raise Awareness of the Burden of Allergies and Need For Appropriate Diagnosis and Treatment

November 8, 2012

TEMPE, Ariz.--(BUSINESS WIRE)--CRA Holdings, LLC announced today that it has acquired Radiant Research, Inc. CRA Holdings is the company that also owns Clinical Research Advantage (CRA), another major player in the SMO market.

November 8, 2012

RENO, Nev. & BONADUZ, Switzerland--(BUSINESS WIRE)--Hamilton Robotics in collaboration with GE Healthcare Life Sciences introduces the easyPunch STARlet™ workstation, the first fully automated system integrating sample card punching.

November 8, 2012

LEXINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Leading European Research Institutions Select RainDance’s ThunderStorm™ System for High-Throughput Targeted Sequencing

November 8, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier healthcare alliance experts to discuss reform, data integration and waste management in November

November 8, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Dr. Laurence Corash, Cerus' chief medical officer, is scheduled to present at the Stephens Fall Investment Conference in New York at 1:00 PM ET on Wednesday, November 14, 2012.

November 8, 2012

AMSTERDAM--(BUSINESS WIRE)--AIMM Therapeutics, a next generation antibody company co-founded by Hergen Spits, PhD, today announced the appointment of Jan de Vries, PhD, as CEO and John Womelsdorf, PhD, as VP BD.

November 8, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay, announced today that during a presentation at the American Heart Association Scientific Sessions in Los Angeles, the results of a study conducted through the Mayo...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus joins a select number of prestigious pharmaceutical and biotechnology companies that have entered into Privileged Partnership Agreements with Proteros.

November 8, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, at 1:00 p.m. Mountain Standard Time. The conference...

November 8, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information study finds that drug manufacturers initiate the majority of Phase IV clinical testing.

November 8, 2012

STOCKHOLM--(BUSINESS WIRE)--Tobii Technology’s partner i2Eye Diagnostics has developed a portable, patient-friendly solution — Saccadic Vector Optokinetic Perimetry (SVOP)— that assists clinicians in the diagnosis of ophthalmic and neurological...

November 8, 2012

SAN DIEGO--(BUSINESS WIRE)--SNMX 3Q12 Results: Market launch of a product containing S6821 Bitter Blocker initiated; regulatory approvals for Savory and Sweet Taste Programs. Call today 11am EST; audio at IR tab,...

November 8, 2012

LEIDEN, The Netherlands & SEATTLE--(BUSINESS WIRE)--ProFibrix Passes Halfway Mark of Patient Enrolment in Pivotal Phase III with Fibrocaps and Successfully Concludes Safety Review Assessment

November 8, 2012

LA JOLLA, Calif.--(BUSINESS WIRE)--Auspex Pharmaceuticals Closes $25 Million Series D Financing; Company Planning to Start Phase 3 Clinical Trial for Treatment of Movement Disorder (Chorea) Associated with Huntington’s Disease.

November 8, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--Inviragen and the International Vaccine Institute (IVI) are conducting studies to determine the incidence, cost and epidemiology of dengue infection in Colombia and Thailand.

November 8, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics CEO Paul R. Edick will present an overview of the company at the Credit Suisse Healthcare Conference at The Arizona Biltmore in Phoenix, AZ on Nov. 15 at 3:00p.m. MST.

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Lazard Capital Markets 9th Annual Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and...

November 8, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc.: GENERAL HIGHLIGHTS Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today: reported record fourth quarter and full-year fiscal 2012 net sales of $43.7 million and $173.5 million,...

November 8, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ: RGEN) today reported financial results for its third quarter and year-to-date period ended September 30, 2012. The Company reported net income for the three-month period ended...

November 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus reports financial results for the third quarter ended September 30, 2012.

November 8, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Corporate Update at Credit Suisse 2012 Healthcare Conference in Phoenix on November 15th

November 8, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2012 Global Healthcare Conference on Thursday November 15, 2012 at...

November 8, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation today announced financial results for the third quarter and nine months ended September 30, 2012.

November 8, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) today reported financial results for the three- and nine-month periods ended September 30, 2012. Highlights of the third quarter include: Total net revenues increased...

November 8, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it has reached an agreement with Glaxo Group Limited (GSK) to terminate their collaboration agreement concerning Horizant® (gabapentin enacarbil) Extended-...

November 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on November 15, 2012 at the Jefferies 2012 Global Healthcare Conference in London, UK. The GTx presentation will begin at 11...

November 8, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today provided a Company update and reported financial results for the third quarter of 2012. “We expect to complete enrollment this quarter in our two pivotal Phase III clinical trials...

November 8, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the third quarter and nine months ended September 30, 2012. “Despite the recent setbacks, we are focused on...

November 8, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica's service revenues increased by 15.7% in the 3Q'12 and its non-GAAP operating income increased 26.1%, as demand for its products increased along with its operating leverage.

November 8, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-U.S. and Non-U.K. Media Boehringer Ingelheim and Eli Lilly and Company are pleased to announce that the recruitment of patients for CAROLINA (Cardiovascular Outcome Study of Linagliptin versus...

November 8, 2012

LOS ANGELES--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only 8 November, 2012--Pivotal data from the RELY-ABLE® study have provided additional data to support the long-term safety profile and efficacy of Pradaxa® (dabigatran...

November 8, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG): New results from re-evaluation of two separate and previously performed clinical trials show that DiaGenic’s technology has the potential to differentiate dementia due to...

November 8, 2012

HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (“EpiCept”) (NASDAQ OMX Stockholm Exchange and OTCQX: EPCT) today...